Prevention of NSAID-induced small intestinal mucosal injury: Prophylactic potential of lansoprazole

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 2, 2009, Pages 125-130

  Higuchi, Kazuhide ^a   Yoda, Yukiko ^a   Amagase, Kikuko ^b   Kato, Shinichi ^b   Tokioka, Satoshi ^a   Murano, Mitsuyuki ^a   Takeuchi, Koji ^b   Umegaki, Eiji ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Lansoprazole; NSAID; PPI; Small intestinal injury

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1; INDOMETACIN; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CAPSULE ENDOSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BALLOON ENTEROSCOPY; DRUG INDUCED DISEASE; HUMAN; INTESTINE INJURY; INTESTINE ULCER; MALE; NONHUMAN; RAT; REVIEW; RHEUMATOID ARTHRITIS; SMALL INTESTINE DISEASE; SMALL INTESTINE MUCOSA; STOMACH PROTECTION;

EID: 70350337447     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.SR09-58     Document Type: Review

References (51)

1. Higuchi, K., Umegaki, E., Watanabe, T., Yoda, Y., Morita, E., Murano, M., Tokioka, S., and Arakawa, T.: Present Status and strategy of NSAIDs-induced small bowel injury. J. Gastroenterol., Jul 1 2009 [Epub ahead of print].
2. Graham, D.Y., Opekun, A.R., Willingham, F.F., and Qureshi, W.A.: Visible small-intestinal mucosal injury in chronic NSAID users. Clin. Gastroenterol. Hepatol., 3, 55-59, 2005.
3. Kameda, N., Higuchi, K., Shiba, M., Machida, H., Okazaki, H., Yamagami, H., Tanigawa, T., Watanabe, K., Watanabe, T., Tominaga, K., Fujiwara, Y., Oshitani, N., and Arakawa, T.: A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. J. Gastroenterol., 43, 434-440, 2008.
4. Watanabe, T., Sugimori, S., Kameda, N., Machida, H., Okazaki, H., Tanigawa, T., Watanabe, K., Tominaga, K., Fujiwara, Y., Oshitani, N., Higuchi, K., and Arakawa, T.: Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin. Gastroenterol. Hepatol., 6, 1279-1282, 2008.
5. Sugimori, S., Watanabe, T., Tabuchi, M., Kameda, N., Machida, H., Okazaki, H., Tanigawa, T., Yamagami, H., Shiba, M., Watanabe, K., Tominaga, K., Fujiwara, Y., Oshitani, N., Koike, T., Higuchi, K., and Arakawa, T.: Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion, 78, 208-213, 2008.
6. Konaka, A., Tanaka, A., Kato, S., Nishijima, M., and Takeuchi, K.: Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced intestinal lesions in rats. J. Pharmacol. Physiol., 50, 25-38, 1999.
7. Takeuchi, K., Miyazawa, T., Tanaka, A., Kato, S., and Kunikata, T.: Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion, 66, 30-41, 2002. (Pubitemid 36151288)
8. Whittle, B.J.: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology, 80, 94-98, 1981.
9. Boughton-Smith, N.K., Evans, S.M., Laszlo, F., Whittle, B.J., and Moncada, S.: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol., 110, 1189-1195, 1993.
10. Whittle, B.J.R., Laszlo, F., Evans, S.M., and Moncada, S.: Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br. J. Pharmacol., 116, 2286-2290, 1995.
11. Tanaka, A., Kunihata, T., Mizoguchi, H., Kato, S., and Takeuchi, K.: Dual action of nitric oxide in pathogenesis of indometachin-induced small intestinal ulceration in rats. J. Physiol. Pharmacol., 50, 405-417, 1999.
12. Bjarnason, I., Hayllar, J., MacPherson, A.J., and Russell, A.S.: Side effects of nonsteroidal anti-inflammatory drugs on the small intestine in humans. Gastroenterology, 104, 1832-1847, 1993.
13. Robert, A. and Asano, T.: Resistance of germ-free rats to indomethacin-induced intestinal inflammation. Prostaglandins, 14, 333-341, 1977.
14. Watanabe, T., Higuchi, K., Kobata, A., Nishio, H., Tanigawa, T., Shiba, M., Tominaga, K., Fujiwara, Y., Oshitani, N., Asahara, T., Nomoto, K., Takeuchi, K., and Arakawa, T.: Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut, 57, 181-187, 2008. (Pubitemid 351158044)
15. Sigthorsson, G., Simpson, R.J., Walley, M., Anthony, A., Foster, R., Hotz-Behoftsitz, C., Palizban, A., Pombo, J., Watts, J., Morham, S.G., and Bjarnason, I.: COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology, 122, 1913-1923, 2002.
16. Langtry, H.D. and Wilde, M.I.: Omeprazole. A review of its use in Helicobacter pylori infection, gastro-esophageal reflux disease and peptic ulcers impaired by non-steroidal anti-inflammatory drugs. Drugs, 56, 447-486, 1998.
17. + ATPase. Annu. Rev. Pharmacol. Toxicol., 35, 277-305, 1995.
18. Hawkey, C.J., Karrasch, J.A., Szczepañski, L., Walker, D.G., Barkun, A., Swannell, A.J., and Yeomans, N.D.: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) study Group. N. Engl. J. Med, 338, 727-734, 1998.
19. Fukuda, T., Arakawa, T., Shimizu, Y., Ohtani, K., Higuchi, K., and Kobayashi, K.: Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa. J. Clin. Gastroenterol., 20, S5-S7, 1995.
20. Natale, G., Lazzeri, G., Lubrano, V., Colucci, R., Vassalle, C., Fornai, M., Blandizzi, C., and Del Tacca, M.: Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol. Appl. Pharmacol., 195, 62-72, 2004.
21. Fornai, M., Natale, G., Colucci, R., Tuccori, M., Carazzina, G., Antonioli, L., Baldi, S., Lubrano, V., Abramo, A., Blandizzi, C., and Del Tacca, M.: Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn Schmiedebergs Arch. Pharmacol., 372, 79-87, 2005.
22. Wandall, J.H.: Effect of omeplazole on neutrophil chemotaxis, super oxide production, degranulation and tranlocation of cytochrome b-245. Gut, 33, 617-621, 1992.
23. Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., and Kondo, M.: A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther., 14, S74-S81, 2000.
24. Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., and Banerjee, R.K.: A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem., 278, 10993-11001, 2003.
25. Ichikawa, H., Yoshida, N., Takagi, T., Tomatsuri, N., Katada, K., Isozaki, Y., Uchiyama, K., Naito, Y., Okanoue, T., and Yoshikawa, T.: Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World J. Gastroenterol., 10, 2814-2817, 2004.
26. Kuroda, M., Yoshida, N., Ichikawa, H., Takagi, T., Okuda, T., Naito, Y., Okanoue, T., and Yoshikawa, T.: Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int. J. Mol. Med., 17, 89-93, 2006.
27. Pozzoli, C., Menozzi, A., Grandi, D., Solenghi, E., Ossiprandi, M.C., Zullian, C., Bertini, S., Cavestro, G.M., and Coruzzi, G.: Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn-Schmiedebergs Arch. Pharmacol., 374, 283-291, 2007.
28. Yoda, Y., Takeuchi, K., Kato, S., Amagase, K., Umegaki, E., Tokioka, S., and Higuchi, K.: Search for prophylactic drugs against NSAID-induced small Intestinal lesions in rats. Gastroenterology, 134, suppl. 1, A-528, 2008.
29. Naito, Y.: Anti-inflammatory and anti-oxidative properties of proton pump inhibitors. J. Clin. Biochem. Nutr., 41, 82-83, 2007.
30. Isomoto, H., Nishi, Y., Kanazawa, Y., Shikuwa, S., Mizuta, Y., Inoue, K., and Kohno, S.: Immune and inflammatory responses in GERD and lansoprazole. J. Clin. Biochem. Nutr., 41, 84-89, 2007.
31. Mine, S. and Tanaka, Y.: Lansoprazole-induced improvement of esophageal submucosal injury. J. Clin. Biochem. Nutr., 41, 92-96, 2007.
32. Nakamura, M., Matsui, H., Serizawa, H., and Tsuchimoto, K.: Lansoprazole novel effector sites revealed by autoradiography: relation to Helicobacter pylori, colon, esophagus and others. J. Clin. Biochem. Nutr., 41, 154-159, 2007.
33. Tomisato, W., Tanaka, K., Katsu, T., Kakuta, H., Sasaki, K., Tsutsumi, S., Hoshino, T., Aburaya, M., Li, D., Tsuchiya, T., Suzuki, K., Yokomizo, K., and Mizushima, T.: Role of direct cytotoxic effects of NSAlDs in the induction of gastric lesions. Biochem. Pharmacol., 67, 575-585, 2004.
34. Tomisato, W., Tanaka, K., Katsu, T., Kakuta, H., Sasaki, K., Tsutsumi, S., Hoshino, T., Aburaya, M., Li, D., Tsuchiya, T., Suzuki, K., Yokomizo, K., and Mizushima, T.: Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun., 323, 1032-1039, 2004.
35. Tenhunen, R., Marver, H.S., and Schmid, R.: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci., 61, 748-755, 1968.
36. Maines, M.D.: The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol., 37, 517-554, 1997.
37. Takahashi, T., Shimizu, H., Morimatsu, H., Maeshima, K., Inoue, K., Akagi, R., Matsumi, M., Katayama, H., and Morita, K.: Heme Oxygenase-1 is an Essential Cytoprotective Component in Oxidative Tissue Injury Induced by Hemorrhagic Shock. J. Clin. Biochem. Nutr., 44, 28-40, 2009.
38. Otterbein, L.E., Mantell, L.L., and Cho, A.M.: Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol., 276, L688-L694, 1999.
39. Morisaki, H., Katayama, T., Kotake, Y., Ito, M., Handa, M., Ikeda, Y., Takeda, J., and Suematsu, M.: Carbon monoxide modulates endotoxin-induced micoravascular leukocyte adhesion through platelet-dependent mechanisms. Anesthesiology, 97, 701-709, 2002. (Pubitemid 34977331)
40. Sato, K., Balla, J., Otterbein, L., Smith, R.N., Brouard, S., Lin, Y., Csizmadia, E., Sevigny, J., Robson, S.C., Vercellotti, G., Choi, A.M., Bach, F.H., and Soares, M.P.: Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol., 166, 4185-4194, 2001. (Pubitemid 32224952)
41. Mizushima, T.: Induction of HO-1 by NSAIDs and its role in NSAID-induced gastric ulcers. Nippon Yakurigaku Zasshi, 130, 262-265, 2007.
42. Morse, D. and Choi, A.M.: Heme oxygenase-1: the "emerging molecule" has arrived. Am. J. Respir. Cell Mol. Biol., 27, 8-16, 2002.
43. Otterbein, L.E., Soares, M.P., Yamashita, K., and Bach, F.H.: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol., 24, 49-55, 2003.
44. Becker, J.C., Grosser, N., Waltke, C., Schulz, S., Erdmann, K., Domschke, W., Schröder, H., and Pohle, T.: Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem. Biophys. Res. Commun., 345, 1014-1021, 2006.
45. Yoda, Y., Higuchi, K., Takeuchi, K., Umegaki, E., Tokioka, S., Kato, S., and Amagase, K.: Proton pump inhibitor (PPI), lansoprazole prevents indomethacin-induced small intestinal ulceration in rats: Involvement of Heme Oxygenase (HO)-1. Gastroenterology, 136, suppl. 1, A-684, 2009.
46. Sawle, P., Foresti, R., Mann, B.E., Johnson, T.R., Green, C.J., and Motterlini, R.: Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol., 145, 800-810, 2005.
47. Bani-Hni, M.G., Greenstein, D., Mann, B.E., Green, C.J., and Motterlini, R.: Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3. J. Pharmacol. Exp. Ther., 318, 1315-1322, 2006.
48. Dijkstra, G., Blokzil, H., Homan, M., van Goor, H., Faber, K.N., Jansen, P.L., and Moshage, H.: Opposite effect of oxidative stress on inducible nitric oxide synthase and heam oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J. Pathol., 204, 296-303, 2004.
49. Minamoto, K., Harada, H., Lama, V.N., Fedarau, M.A., and Pinsky, D.J.: Reciprocal regulation airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase. J. Exp. Med., 202, 283-294, 2005.
50. Megias, J., Busserolles, J., and Alcaraz, M.J.: The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells. Br. J. Pharmacol., 150, 977-986, 2007.
51. Kato, S., Nishio, H., Ogura, M., and Takeuchi, K.: Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin-induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression. J. Pharmacol. Sci., 103, 40-47, 2007.